Literature DB >> 30498423

Intraductal Papilloma Without Atypia on Image- Guided Breast Biopsy: Upgrade Rates to Carcinoma at Surgical Excision.

Doris Leithner1, Benjamin Kaltenbach1, Petra Hödl2, Volker Möbus3, Volker Brandenbusch4, Stephan Falk5, Clara Park1, Thomas J Vogl1, Markus Müller-Schimpfle6.   

Abstract

BACKGROUND: The management of intraductal papilloma without atypia (IDP) in breast needle biopsy remains controversial. This study investigates the upgrade rate of IDP to carcinoma and clinical and radiologic features predictive of an upgrade.
METHODS: Patients with a diagnosis of IDP on image-guided (mammography, ultrasound, magnetic resonance imaging) core needle or vacuum-assisted biopsy and surgical excision of this lesion at a certified breast center between 2007 and 2017 were included in this institutional review board-approved retrospective study. Appropriate statistical tests were performed to assess clinical and radiologic characteristics associated with an upgrade to malignancy at excision.
RESULTS: For 60 women with 62 surgically removed IDPs, the upgrade rate to malignancy was 16.1% (10 upgrades, 4 invasive ductal carcinoma, 6 ductal carcinoma in situ). IDPs with upgrade to carcinoma showed a significantly greater distance to the nipple (63.5 vs. 36.8 mm; p = 0.012). No significant associations were found between upgrade to carcinoma and age, menopausal status, lesion size, microcalcifications, BI-RADS descriptors, initial BI-RADS category, and biopsy modality.
CONCLUSION: The upgrade rate at excision for IDPs diagnosed with needle biopsy was higher than expected according to some guideline recommendations. Observation only might not be appropriate for all patients with IDP, particularly for those with peripheral IDP.

Entities:  

Keywords:  Biopsy; Breast cancer; Imaging; Papilloma

Year:  2018        PMID: 30498423      PMCID: PMC6257098          DOI: 10.1159/000489096

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  28 in total

1.  Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy?

Authors:  Laura Liberman; Carmen Tornos; Renata Huzjan; Lia Bartella; Elizabeth A Morris; D David Dershaw
Journal:  AJR Am J Roentgenol       Date:  2006-05       Impact factor: 3.959

2.  Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation?

Authors:  Soo-Yeon Kim; Eun-Kyung Kim; Hye Sun Lee; Min Jung Kim; Jung Hyun Yoon; Ja Seung Koo; Hee Jung Moon
Journal:  Ann Surg Oncol       Date:  2016-02-26       Impact factor: 5.344

3.  Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up.

Authors:  Monica Rizzo; Jared Linebarger; Michael C Lowe; Lin Pan; Sheryl G A Gabram; Leonel Vasquez; Michael A Cohen; Marina Mosunjac
Journal:  J Am Coll Surg       Date:  2012-01-11       Impact factor: 6.113

4.  Risk factors for malignancy in benign papillomas of the breast on core needle biopsy.

Authors:  So-Youn Jung; Han-Sung Kang; Youngmee Kwon; Sun Young Min; Eun-A Kim; Kyoung Lan Ko; Seeyoun Lee; Seok Won Kim
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

5.  Papillary lesions of the breast at percutaneous core-needle biopsy.

Authors:  Cecilia L Mercado; Diane Hamele-Bena; Shara M Oken; Cory I Singer; Joan Cangiarella
Journal:  Radiology       Date:  2006-01-19       Impact factor: 11.105

6.  Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.

Authors:  Andrew A Renshaw; Robert P Derhagopian; Dolores M Tizol-Blanco; Edwin W Gould
Journal:  Am J Clin Pathol       Date:  2004-08       Impact factor: 2.493

7.  Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision?

Authors:  Roger J Jackman; Robyn L Birdwell; Debra M Ikeda
Journal:  Radiology       Date:  2002-08       Impact factor: 11.105

8.  Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome.

Authors:  Nasim Ahmadiyeh; Mariana A Stoleru; Sughra Raza; Susan C Lester; Mehra Golshan
Journal:  Ann Surg Oncol       Date:  2009-05-30       Impact factor: 5.344

Review 9.  Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?

Authors:  Timothy W Jacobs; James L Connolly; Stuart J Schnitt
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

10.  Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: Rate of upgrade to carcinoma at excision.

Authors:  Fresia Pareja; Adriana D Corben; Sandra B Brennan; Melissa P Murray; Zenica L Bowser; Kiran Jakate; Christopher Sebastiano; Monica Morrow; Elizabeth A Morris; Edi Brogi
Journal:  Cancer       Date:  2016-06-17       Impact factor: 6.860

View more
  3 in total

1.  Benign breast papillary lesions diagnosed on core biopsy: upgrade rate and risk factors associated with malignancy on surgical excision.

Authors:  Christine MacColl; Amir Salehi; Sameer Parpia; Nicole Hodgson; Milita Ramonas; Phillip Williams
Journal:  Virchows Arch       Date:  2019-08-01       Impact factor: 4.064

2.  Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.

Authors:  Xiaoli Zhang; Wenqing Liu; Tao Hai; Fei Li
Journal:  Ann Surg Oncol       Date:  2021-07-30       Impact factor: 5.344

Review 3.  High-risk lesions of the breast: concurrent diagnostic tools and management recommendations.

Authors:  Francesca Catanzariti; Daly Avendano; Giuseppe Cicero; Margarita Garza-Montemayor; Carmelo Sofia; Emmanuele Venanzi Rullo; Giorgio Ascenti; Katja Pinker-Domenig; Maria Adele Marino
Journal:  Insights Imaging       Date:  2021-05-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.